₹ 246.37
0.17 (0.07%)
P
Piramal Pharma
₹ 246.37
Piramal Pharma Share Price Today
Piramal Pharma (PPLPHARMA) share price is trading at ₹246.37 on the NSE as of November 9, 2026 at 03:53 PM, up by 0.07% from its previous close of ₹246.20. In todays trading session PPLPHARMA reached a high of 250.40 and low of 242.50. The average traded price for today is 247.04. The 50 DMA stands at 211.80 and 200 DMA is at 179.49. Looking at intraday trend, the stock is moving sideways.
Stock Overview
- Symbol : PPLPHARMA
- Open : ₹247.10
- Previous Close : ₹246.20
- Day's Range : ₹242.50 – ₹250.40
- 52-Week Range : ₹132.30 – ₹250.40
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
PPLPHARMA Stock Performance
Markets Today
High
250.40
Low
242.50
Open at
247.10
Prev Close
246.20
Volumes
54,61,836
Avg Price
247.04
Lower Circuit
197.10
Upper Circuit
295.64
Last Traded Details
Quantity
200
Time
15:53:10
Price Movement
Historical Performance
3 M High
250.40
3 M Low
185.02
1 Yr High
250.40
1 Yr Low
132.30
3 Yr High
307.90
3 Yr Low
95.30
5 Yr High
307.90
5 Yr Low
61.62
1-Year Performance
PPLPHARMA Pros and Cons
CDMO revenue grows from USD 1,044 in Q2 FY26 to USD 1,424 in Q2 FY27 — stronger contract manufacturing demand
CHG revenue grows from ₹644 Cr in Q2 FY26 to ₹849 Cr in Q2 FY27 — consumer health demand lifts the segment
PCH revenue grows from ₹319 Cr in Q2 FY26 to ₹359 Cr in Q2 FY27 — branded consumer products keep expanding
EBITDA margin improves from 11% in Q2 FY26 to 14.7% in Q2 FY27 — operating leverage supports profitability
Revenue from operations grows from ₹2,044 Cr in Q2 FY26 to ₹2,617 Cr in Q2 FY27 — consolidated top line expands
Net debt rises from ₹3,971 Cr in Q2 FY26 to ₹4,859 Cr in Q2 FY27 — higher leverage adds balance-sheet pressure
Material cost rises from ₹703 Cr in Q2 FY26 to ₹906 Cr in Q2 FY27 — input costs remain a key margin headwind
Employee expenses rise from ₹611 Cr in Q2 FY26 to ₹714 Cr in Q2 FY27 — staffing costs add to operating pressure
Depreciation rises from ₹203 Cr in Q2 FY26 to ₹233 Cr in Q2 FY27 — higher asset base weighs on earnings
Other income falls from ₹66 Cr in Q2 FY26 to ₹36 Cr in Q2 FY27 — lower non-operating income reduces cushion
PPLPHARMA Analyst Rating
Buy
Analysts have suggested that investors can
Buy this Stock
- By Refinitiv from 10 analysts
Buy
100%
Hold
0%
Sell
0%
Get forecast for Price, ROA & ROE based on analyst ratings.
PPLPHARMA Share Price History
PPLPHARMA Fundamentals
Company Valuation
Market Cap (₹ Cr.)
32,800
PE Ratio
-156.70
PB Ratio
4.02
Dividend Yield
0.06%
ROE
-3.99%
ROCE
1.25%
Book Value (₹)
61.18
Face Value (₹)
10.00
Analyse PPLPHARMA with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 34.86% | 34.86% | 34.86% | 34.80% | 34.80% |
| Domestic Institutional Investors (DII) | 14.89% | 15.69% | 15.61% | 14.57% | 14.44% |
| Foreign Institutional Investors (FII) | 30.27% | 29.66% | 30.18% | 12.52% | 13.65% |
| Public Investors | 14.12% | 14.11% | 13.74% | 14.54% | 13.27% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Piramal Pharma Return Calculator
Note: Past profits do not guarantee future returns.
PPLPHARMA Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
PPLPHARMA Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for PPLPHARMA
Margin on PPLPHARMA
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
PPLPHARMA Financials Summary
In Crores
PPLPHARMA Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check PPLPHARMA latest Company Filings, Investor Presentation & Conference Call details.
PPLPHARMA Revenue Growth
All values are in Crores
Revenue
Profit
Loss
PPLPHARMA Similar Stocks
FAQs on PPLPHARMA
What is the share price of Piramal Pharma?
What is the 52W high and 52W low of Piramal Pharma?
What is the return on Piramal Pharma share?
- Past 1 year: 23.71%
- Past 3 years: 113.12%
- Past 5 years: 32.78%
What is the PE and PB Ratio of Piramal Pharma?
What is the EPS of Piramal Pharma?
What is the shareholding pattern of Piramal Pharma?
- DIIs - 14.44%
- FII - 13.65%
- Promoters - 34.80%
- Public Investors 13.27%
- Goverenment - 0.00%
How to buy Piramal Pharma shares online?
How to buy Piramal Pharma shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Piramal Pharma share
- Tap on “Buy”
